A novel long non-coding RNA-ARA: adriamycin resistance-associated - PubMed (original) (raw)
. 2014 Jan 15;87(2):254-83.
doi: 10.1016/j.bcp.2013.10.020. Epub 2013 Oct 30.
Ou Huang 2, Zuoquan Xie 3, Shuchao Wu 3, Xi Zhang 2, Aijun Shen 3, Hongchun Liu 3, Xiaosong Chen 2, Jiayi Wu 2, Ying Lou 2, Yan Mao 2, Kan Sun 4, Shudong Hu 5, Meiyu Geng 6, Kunwei Shen 7
Affiliations
- PMID: 24184505
- DOI: 10.1016/j.bcp.2013.10.020
A novel long non-coding RNA-ARA: adriamycin resistance-associated
Min Jiang et al. Biochem Pharmacol. 2014.
Erratum in
- Corrigendum to "A novel long non-coding RNA-ARA: Adriamycin resistance-associated" [Biochem. Pharmacol. 87 (2014) 254-283].
Jiang M, Huang O, Xie Z, Wu S, Zhang X, Shen A, Liu H, Chen X, Wu J, Lou Y, Mao Y, Sun K, Hu S, Geng M, Shen K. Jiang M, et al. Biochem Pharmacol. 2020 Feb;172:113732. doi: 10.1016/j.bcp.2019.113732. Epub 2019 Dec 21. Biochem Pharmacol. 2020. PMID: 31869579 No abstract available.
Abstract
Long non-coding RNAs (lncRNAs) are emerging as an integral functional component of human genome and have been investigated as critical regulators in molecular biology of cancer. A recent study reported that lncRNA-UCA1 induced drug resistance in adriamycin chemotherapy. However, the contributions of lncRNAs to adriamycin resistance in cancers remain largely unknown. To address this issue, we performed a genome-wide lncRNA microarray analysis in adriamycin resistant MCF-7/ADR and parental MCF-7 cells, and revealed differential expression of lncRNAs in distinct category and chromosome distribution patterns. A specific differentially expressed lncRNA (Adriamycin Resistance Associated, termed ARA) was validated in MCF-7/ADR and HepG2/ADR cells. ARA is derived from an intron of PAK3 gene, predicted to contain several stable hairpins in secondary structure and has conservative sequences in primates. ARA expression is significantly associated with adriamycin sensitivity in a panel of breast and liver cancer cell lines and is markedly up-regulated in parental sensitive MCF-7 and HepG2 cell lines after receiving adriamycin treatment. The functions of ARA were assessed by silencing this lncRNA in vitro, and we found that ARA knockdown reduced the proliferation, induced cell death, G2/M arrest and migration defects. Furthermore, microarray transcriptomic analysis was carried out to comprehensively depict the ARA-regulated genes. We showed that ARA can modulate multiple signalling pathways, including MAPK signalling pathway, metabolism pathways, cell cycle and cell adhesion-related biological pathways, and regulate cellular processes, including transcriptional processes and protein binding function. Overall, our results indicate novel insights of adriamycin resistance in lncRNA level.
Keywords: ARA: Adriamycin resistance associated; Adriamycin Resistance; Breast cancer; Liver cancer; Long non-coding RNA.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Mechanism of aberrant long non-coding RNA expression in an adriamycin-resistant liver cancer cell strain.
Wang Y, Wan G, Wang H, Zhang G, Li Z, Lu L, Wu Y, Yu X, Du J. Wang Y, et al. Dig Liver Dis. 2020 May;52(5):582-587. doi: 10.1016/j.dld.2019.09.013. Epub 2019 Nov 6. Dig Liver Dis. 2020. PMID: 31704308 - Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C, Guo Y, Zhang J, Huang B. Shang C, et al. Cancer Chemother Pharmacol. 2016 May;77(5):1061-7. doi: 10.1007/s00280-016-3029-3. Epub 2016 Apr 7. Cancer Chemother Pharmacol. 2016. PMID: 27056384 - Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells.
Huang L, Zeng L, Chu J, Xu P, Lv M, Xu J, Wen J, Li W, Wang L, Wu X, Fu Z, Xie H, Wang S. Huang L, et al. Mol Med Rep. 2018 Jul;18(1):243-253. doi: 10.3892/mmr.2018.8942. Epub 2018 Apr 27. Mol Med Rep. 2018. PMID: 29749447 Free PMC article. - miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J, Xia K, Xu P, Sun E, Ma J, Gao S, Zhou Q, Zhang M, Wang F, Chen F, Zhou P, Fu Z, Xie H. Lv J, et al. Biomed Pharmacother. 2014 Oct;68(8):935-42. doi: 10.1016/j.biopha.2014.09.011. Epub 2014 Oct 5. Biomed Pharmacother. 2014. PMID: 25451164 - Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.
Zhang HB, Hu Y, Deng JL, Fang GY, Zeng Y. Zhang HB, et al. Front Pharmacol. 2023 Sep 15;14:1243934. doi: 10.3389/fphar.2023.1243934. eCollection 2023. Front Pharmacol. 2023. PMID: 37781691 Free PMC article. Review.
Cited by
- Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.
Ahmadpour ST, Orre C, Bertevello PS, Mirebeau-Prunier D, Dumas JF, Desquiret-Dumas V. Ahmadpour ST, et al. Int J Mol Sci. 2023 Nov 2;24(21):15897. doi: 10.3390/ijms242115897. Int J Mol Sci. 2023. PMID: 37958880 Free PMC article. Review. - Deciphering the roles of lncRNAs in breast development and disease.
Richard JLC, Eichhorn PJA. Richard JLC, et al. Oncotarget. 2018 Feb 28;9(28):20179-20212. doi: 10.18632/oncotarget.24591. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29732012 Free PMC article. Review. - Identification of lncRNAs via microarray analysis for predicting HER2-negative breast cancer response to neoadjuvant chemotherapy.
Ouyang D, Su J, Huang P, Li M, Li Q, Zhao P, Chen Q, Zou Q, Feng X, Qian K, Li L, Yi W. Ouyang D, et al. Int J Clin Exp Pathol. 2018 May 1;11(5):2621-2628. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938376 Free PMC article. - ARA lncRNA, is upregulated in liver and breast tumor tissues.
Raeisi F, Abolfathi M, Ahmadi-Naji R, Iranparast S, Noshadi E, Akbari A, Mahmoudi E, Khaledi M, Arshi A. Raeisi F, et al. Mol Biol Rep. 2019 Feb;46(1):77-82. doi: 10.1007/s11033-018-4447-6. Epub 2018 Oct 26. Mol Biol Rep. 2019. PMID: 30367404 - Up-regulation of FOXN3-AS1 in invasive ductal carcinoma of breast cancer patients.
Molaei Ramshe S, Ghaedi H, Omrani MD, Geranpayeh L, Alipour B, Ghafouri-Fard S. Molaei Ramshe S, et al. Heliyon. 2021 Oct 14;7(10):e08179. doi: 10.1016/j.heliyon.2021.e08179. eCollection 2021 Oct. Heliyon. 2021. PMID: 34703931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials